Paul J. Schenarts MD, FACS

Normal Aging Changes Age-related changes in sensation and perception can have great influence anxiety symptoms ruining my life discount imipramine 25 mg line, isolating an individual from the surrounding environment and triggering complex psychological reactions anxiety oils cheap imipramine express. There may be diminution of hearing and vision anxiety 6 weeks pregnant imipramine 25 mg order amex, slowing of intellectual and physical response time anxiety service dog order imipramine 75 mg amex, and increasing difficulty with memory anxiety symptoms zinc generic imipramine 25 mg overnight delivery. Many physical and intellectual abilities, however, are retained throughout life, and their loss should not be assumed to be part of the normal aging process. These include the senses of taste and smell, intelligence, the ability to learn, and sexuality. Any change in physical, intellectual, or emotional capabilities may reflect underlying organic or psychological disease. Depression Depression is the most frequent psychiatric problem in the older population. Approximately onequarter of older patients seen in primary care settings are clinically depressed. The prevalence of depression in patients with macular degeneration is even higher, at 30%­40%. The suicide rate in white American men older than 65 years is 5 times greater than that of the general population; loneliness is the main reason cited, along with financial problems and poor health. Successful suicide is much less common in older American women, but older women attempt suicide more often than do men. Major depressive disorder is characterized by episodes of at least 2 weeks of depressed mood or loss of interest or pleasure in activities with 4 or more of the following symptoms: changes in appetite with associated weight loss or gain significant weight loss or gain sleep disturbance agitation diminished libido retardation (slowing down) loss of energy feelings of worthlessness or guilt difficulties in concentration and decision making recurrent thoughts of suicide or death the signs and symptoms of depression in older individuals are similar to those seen in younger age groups, although older depressed patients are more likely than younger patients to have somatic or hypochondriacal complaints, minimize depression symptoms (masked depression), and have psychotic delusional disease. The most frequent presentations of subclinical depression include new medical complaints, fatigue, poor concentration, exacerbation of existing symptoms and medical problems, preoccupation with health, and diminished interest in pleasurable activities. For instance, loss of function, such as moderate or severe vision loss, can precipitate depression, as can recent death of a spouse. Red flags may include frequent visits to the ophthalmology office and unexplained vision loss. Though not prevalent in the ophthalmology setting, testing for depression would be enormously helpful in attaining care for those patients who have this disorder. Many case-finding instruments ask about depressed mood and anhedonia, the latter defined as a psychological condition characterized by inability to experience pleasure in acts that normally produce it. Most of these instruments require more time than is available in the typical office practice. It does not suggest or establish a final diagnosis or monitor depression severity, but screens for depression in a "first step" approach. During the past month, have you been bothered by feeling down, depressed, or hopeless During the past month, have you often been bothered by little interest or pleasure in doing things If the first question is answered in the affirmative, it is highly likely that the patient has depression. The added sensitivity and greater specificity provided by the second question, if answered in the affirmative, makes it worthwhile to ask the questions. The ophthalmologist may conclude that further evaluation by the primary care physician is necessary. Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects. Alzheimer Disease and Dementia Alzheimer disease and dementia are discussed in Chapter 11. Osteoporosis Osteoporosis is defined by the World Health Organization as a disease "characterized by low bone mass and micro-architectural deterioration of bone tissue, leading to bone fragility and a consequent increase in risk of fracture. It is estimated that 1 of every 2 women and 1 of every 4 men older than 50 years will have an osteoporosis-related fracture. Those with hip fractures have a 20% risk of entering a nursing home within a year of their fracture, and it is estimated that almost 50% of women with hip fractures do not fully regain previous function. Many patients with hip fractures experience a decline in function, along with increased feelings of isolation, depression, and fear of falling. In the context of osteoporosis, the potential for falling becomes even more important. For the ophthalmologist, it is important to note what medications are being taken by a patient with osteoporosis. One of the drugs that can affect eye health is the class of drugs known as bisphosphonates, which are often prescribed for postmenopausal women to inhibit bone resorption. These drugs are associated with inflammatory disease of the eye, including conjunctivitis, uveitis, and episcleritis. On the other hand, a study of veterans revealed that the rates of uveitis/scleritis following dispensing of a bisphosphonate drug were low and did not differ significantly from those of the control group. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. In 2010, about 21,700 older adults in the United States died as a result of unintentional fall injuries. Also, there are differences in fatal fall rates among ethnic groups; older non-Hispanic persons have higher fatal fall rates than do older Hispanic persons. Fear of falling causes elderly persons to limit activities, leading to reduced physical fitness, which, in turn, increases the actual risk of falling. Those patients with reduced vision from eye disease, most often macular degeneration, are at the highest risk of falling. Fatalities and injuries from falls among older adults-United States, 1993­2003 and 2001­2005. Motor vehicle and fall related deaths among older Americans 1990­98: sex, race, and ethnic disparities. Ophthalmologists should be aware that newer antipsychotic agents have also been associated with an increased risk for diabetes mellitus. A meta-analysis of the literature on the pharmacologic treatment of dementia indicates that none of the currently available agents can significantly improve cognition, although there may be a mild effect in some patients. The Medicare Improvements for Patients and Providers Act and the Mental Health Parity and Addiction Equity Act of 2008 represent attempts to ensure that psychiatric conditions are given parity with other medical conditions when it comes to insurance coverage. The antiepileptic medications topiramate and vigabatrin are associated with adverse ophthalmic effects. Topiramate can cause angle-closure glaucoma, and vigabatrin can cause visual field loss. This approach has emphasized the public health importance of behavioral and neurologic disorders, which in 2000 accounted for 12. It is estimated that such disorders will account for 15% of disability-adjusted life-years in 2030. In addition to behavioral disorders, neurologic disorders that significantly affect this disease burden include epilepsy, dementias (in particular, Alzheimer disease), multiple sclerosis, Parkinson disease and other motor system disorders, stroke, pain syndromes, and brain injury. Behavioral Disorders Behavioral disorders encompass a wide variety of conditions in which the common factor is disordered functioning of thinking, behavior, and/or interpersonal relationships. Such disorders may profoundly affect the diagnosis and treatment of ophthalmic diseases. In addition, some of the medications used to treat psychiatric disorders may have significant adverse ophthalmic effects. It is estimated that, in the United States, only 20%­25% of patients with depression and other mental health conditions receive effective care. Coverage for mental health services has been substantially improved following the passage of 2 pieces of legislation: the Medicare Improvements for Patients and Providers Act, in which Medicare began reimbursing outpatient mental health treatment services at parity with other Part B services, and the Mental Health Parity and Addiction Equity Act of 2008, which bans employers and insurers from imposing stricter limits on coverage for mental health and substance-use conditions compared with those set for other health problems. Mental Disorders Due to a General Medical Condition Formerly called organic mental syndromes, mental disorders due to a general medical condition are psychological or behavioral abnormalities associated with transient or permanent dysfunction of the brain. Causes include any disease, drug, or trauma that directly affects the central nervous system and systemic illnesses that indirectly interfere with brain function; Alzheimer disease is included in the latter category. Orientation, memory, and other intellectual functions are impaired, often with subsequent behavioral manifestations. Psychiatric symptoms such as hallucinations, delusions, depression, obsessions, and personality changes may occur. Patients with a mental disorder due to a general medical condition, either with or without cognitive impairment, are often unable to remember instructions and therefore unable to adhere to treatment regimens. This general inability to understand instructions, integrate information, and perform tasks is referred to as executive function deficit. Depression, which frequently accompanies the syndrome, can complicate the situation. Medications with adverse effects on the central nervous system, such as -blockers, steroids, and carbonic anhydrase inhibitors, must be used with care because patients are often sensitive to these agents. Schizophrenia Schizophrenia is a mental disorder that alters thought processes and impairs emotional responses. It is one of the most devastating mental illnesses in terms of personal and societal costs, causing significant dysfunction. Schizophrenia usually begins when patients are young and continues to a greater or lesser extent throughout their lives. The hallmarks of schizophrenia include hallucinations, delusions, disorganized thinking, and "negative" symptoms such as emotional and cognitive blunting and social and occupational dysfunction. Motor disturbances range from uncontrolled, aimless activity to catatonic stupor, in which the patient may be immobile, mute, and unresponsive yet fully conscious. Repetitive, purposeless mannerisms and an inability to complete goal-directed tasks are also common. Patients may have other mental health conditions, such as major depression and anxiety disorders. Alternatively, manifestations of schizophrenia can be confused with symptoms of depression or anxiety. Associated illnesses include schizophreniform disorder, in which schizophrenic manifestations occur for less than 6 months, and brief psychotic disorder, which lasts less than 1 month. Patients with schizoaffective disorder have a significant mood disorder, such as depression, in addition to the psychotic disorder. Mood Disorders Mood disorders, also referred to as affective disorders, range from appropriate reactions to negative life experiences to severe, recurrent, debilitating illnesses. Common to all of these disorders is depressed mood, elevated mood (mania), or alternations between the two. Major depression refers to the condition of patients who have major depressive episodes without any manic symptoms and is far more common than mania. The lifetime risk for major depressive disorder is 10% for men and 20%­25% for women. Affective changes include pervasive and persistent low mood, slowed thought processes, low self-esteem, and loss of interest or pleasure in normal activities. Social withdrawal and psychomotor retardation are observed, although agitation also occurs. Major depression is a disabling condition that causes impairment of basic physical functions, as manifested by sleep disturbances, changes in appetite with associated weight loss or gain, diminished libido, and an inability to experience pleasure (anhedonia). Patients commonly report somatic symptoms such as fatigue and headache, as well as other, nonspecific symptoms. Around 3%­4% of patients with major depression die by suicide, and 60% of all persons who die by suicide had depression or another mood disorder. Patients with dysthymic disorder have chronic, less severe depressive symptoms that do not meet the criteria for major depression. Mania is a period of abnormally and persistently elevated or irritable mood that is sufficiently severe to impair social or occupational functioning. Typical symptoms include euphoria or irritability, grandiosity, decreased need for sleep, increased talkativeness, flight of ideas, and increased goal-directed activity. Formally called manic depression, bipolar disorder is found in approximately 4% of people. Bipolar I disorder describes any illness in which mania is present, whether or not depression occurs. In some patients, mood change may not be apparent, and the illness may manifest in somatic symptoms, leading to timeconsuming, expensive workups. Conversely, in patients known to be depressed, an organic disease may be overlooked as psychosomatic. Appropriate recommendations for psychotherapeutic intervention may be met with resistance, anger, or denial, disrupting the patient­physician relationship. Patients may have difficulty adhering to diagnostic and treatment regimens for medical disorders and surgical procedures. A screening study of older patients attending an ophthalmology clinic showed that 1 in 5 patients suffered from depression. It is estimated that as many as 30%­40% of patients with macular degeneration meet the criteria for depressive disorder. Somatoform Disorders Somatoform disorders are mental conditions characterized by symptoms suggesting physical illness or injury in the absence of physical findings or a known physiological mechanism. The practicing ophthalmologist should be aware of these syndromes because encounters with these patients are common. Conversion disorders are characterized by temporary and involuntary loss or alteration of physical functioning due to psychosocial stress. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, has renamed 2 variants of somatoform disorders. Formerly called hypochondriasis, illness anxiety disorder is a preoccupation with the fear of having or developing a serious disease. In body dysmorphic disorder, the patient believes that his or her body is deformed, even though there is no physical defect, or the patient has an exaggerated concern about a mild physical anomaly. Two other conditions that are not actually somatoform disorders bear mentioning here. Factitious disorders are characterized by willful production, feigning, or exaggeration of physical or psychological signs or symptoms in the absence of external incentives. Treatment requires discovery of the true nature of the physical illness, a carefully planned confrontation, and psychotherapy. Chronic conjunctivitis, keratitis, and even scleritis are the usual ophthalmic presentations of factitious disease.

Isolated hemihypertrophy requires differentiation from hemihypotrophy associated with several syndromes anxiety disorder in children generic 50 mg imipramine visa, hemiatrophy associated with neurologic impairments anxiety symptoms for xanax order imipramine toronto, and hemihypertrophy associated with certain heritable (single gene and chromosomal) and sporadic syndromes anxiety 8 year old cheapest generic imipramine uk. Limb overgrowth due to these identifiable causes often is merely a part of generalized somatic overgrowth symptoms of anxiety imipramine 75 mg order with amex. Generalized overgrowth secondary to maternal diabetes has been attributed to excess glucose and insulin during the prenatal period anxiety symptoms weight loss imipramine 50 mg buy fast delivery. Similarly, an excessive supply of nutrients may be the cause of intrauterine overgrowth in infants of obese mothers. Genetic factors likely play a more dominant role in fetal overgrowth associated with large parents, Beckwith-Wiedemann syndrome, Marshall-Smith syndrome, Weaver syndrome, and certain storage disorders. Segmental overgrowth and hemihypertrophy have long been viewed as good candidates for genetic mosaicism in which the genetic makeup of the affected tissues differs from the balance of the body tissues. Limb asymmetry should be sought when intracranial or renal anomalies are found and when omphalocele is present. However, the disparity in limb size may be too subtle during the second trimester for convincing demonstration. Limb overgrowth represents an important clinical finding that necessitates a careful search for other, less obvious associated features. These features, more than the asymmetry, may determine the prognosis and dictate therapy. Specifically, central nervous system malformations or tumors, deep tissue vascular malformations, renal malformations, and intraabdominal malignancies may occur in association with limb overgrowth. Chromosome studies may document that mosaicism is responsible for the growth asymmetry in a minority of cases. Treatment: Treatment must be directed at the limb overgrowth and at other complications. This procedure is performed more commonly on the lower limbs, but could be used in upper limb asymmetry as well. Alternatively, a built-up shoe may be used to equalize the lower limbs and to help prevent scoliosis. Partial or complete amputation of the macrodactylous toes may be necessary to permit shoe fitting. In contrast, hemihypertrophy, segmental overgrowth, and macrodactyly associated with nevi, hemangiomas, and lipomatous infiltration show progressively disparate growth and pose greater difficulties in treatment. Surgery consisting of joint ablation, epiphysiodesis, and partial amputation are all used but with less satisfactory results. Success in debulking overgrown tissues depends on the extent of involvement and the cause. When there is substantial interference with function, amputation may be the treatment of choice. Prognosis: In some cases of simple macrodactyly and isolated hemihypertrophy, the growth disparity remains static during childhood. Viljoen D, Pearn J, Beighton P: Manifestations and natural history of idiopathic hemihypertrophy: a review of eleven cases. The term osteosclerosis is used to indicate increased density of bone without expansion of the bone. Hyperostosis indicates increased density of bone associated with expansion of the bone. Osteopetrosis (marble bone) also indicates increased density of the bone, but this term is best reserved for specific heritable disorders. Anemia is a prominent feature in recessive osteopetrosis, occurs less often and with less severity in dominant osteopetrosis and Kenny medullary stenosis, and is not to be expected in the other sclerosis conditions. To the contrary, in most conditions in which there is generalized increased density of the bones, an associated fragility is manifested by an increased incidence of fractures. Increased bone density may be generalized, affecting all bones of the membranous and cartilaginous skeleton. Measurement of the thickness of the cortex of the bones of the hands and comparison with standards provides an objective means of diagnosis. Some patients have no symptoms, the diagnosis being made on radiographs taken for unrelated reasons. This is the case for some patients with dominant osteopetrosis, diaphyseal dysplasia (Camurati-Engelmann syndrome), and osteopoikilosis. Pain may also occur in osteopetrosis, the craniotubular dysplasias, melorheostosis, and the cortical hyperostosis of Caffey. Increased bone thickness may cause disfigurement, particularly when the craniofacial bones are involved. Radiographs show generalized increase in bone density of long bones in osteopetrosis at age 1 year (B,C), age 10 years (D,E) and age 27 years (F,G). Localized areas of increased density may be seen in areas of infection, hematoma, or callous formation. Certain heritable conditions, metabolic derangements, and nutritional deficiencies may also cause increased bone density of a segmental or localized nature. Type 1 collagen and hydroxyapatite are the main constituents of bone, but a host of enzymatic, structural, and regulatory proteins are involved in bone remodeling. Mutations in any of the genes that give osteoblast activity an advantage over osteoclast activity may result in the accumulation of excessive bone mass and increased bone density. In most cases, hyperdense bones result from calcium deposition in osteoid that is thickened. Hyperdense bones can, however, result from concentration of calcium salts in an otherwise normal cortex. Right: Irregular cortical density and thickening of phalanges in an adult female with melorheostosis. These disorders are progressive, with the bones showing increased density over time. An increased incidence of complications (anemia, bone fragility, and nerve compression) accompanies this progression. Treatment: the underlying cause and associated complications dictate the therapeutic approach. It ranges from bone marrow/stem cell transplantation and cranial nerve decompression (osteopetrosis) to management of fractures, dental anomalies and hearing loss (dysosteosclerosis) to corticoid administration (Camurati-Engelmann). Prognosis: Quite variable prognosis attends the disorders with increased bone density. Cranial nerve impingement, increased intracranial pressure, hearing loss and fractures are among the complications that influence the quality of life. Beighton P, Durr L, Hamersma H: the clinical features of sclerosteosis: a review of the manifestations in twenty-five affected individuals. Osteopenia indicates a decrease in bone mass due to deficient production of osteoid. Other genetic disorders may show generalized decreased bone density at birth or in later years. Certain other Decreased mineral content of bone becomes manifest clinically as bone pain or fractures. Mild osteoporosis is not symptomatic but is usually noted on radiographs taken for other reasons. Maintenance of bone mass is achieved through balancing the resorptive activity of osteoclasts and the regenerative activity of osteoblasts. Determination of osteoporosis is usually made subjectively from the appearance of the bones on radiographs. Note diminished mineralization of skull, long bones and ribs with multiple fractures. Note absent or decreased ossification of vertebral bodies and pedicules, ischia and pubis, and long bones. The propensity to fracture is reduced with cyclic bisphosphonate treatment (osteogenesis imperfecta, juvenile osteoporosis) and with Vitamin D and Ca administration (vitamin D­dependent rickets, cystinosis). Prognosis: In the nonlethal forms of osteogenesis imperfecta, repeated fractures, bone deformation, and hearing loss are complications. Hemolytic anemia may lead to osteoporosis through expansion of the marrow cavity at the expense of the bony cortex. Rickets and scurvy also cause osteoporosis, rickets by decreased mineral uptake in the intestine, and increased loss through the kidneys and scurvy by an inhibition of bone deposition. Hyperparathyroidism causes increased renal loss of calcium and phosphorus, producing osteoporosis. Most of these causes of decreased bone density are not congenital, although congenital rickets has been reported as has congenital hyperparathyroidism secondary to maternal hypoparathyroidism. Frontali M, Stomeo C, Dallapiccola B: Osteoporosis-pseudoglioma syndrome: report of three affected sibs and an overview. Schajowicz F, Schlullitel J: Eosinophilic granuloma of bone and its relationship to Hand-Schuller-Christian syndrome. Carpal osteolysis in an 11-year-old male with carpotarsal osteolysis and nephropathy. Marked heterogeneity and variability among the osteolyses make for a confusing array of disruptive processes, which can affect virtually any bone of the body and carry life-threatening or inconsequential implications. Osteolysis may be heralded by painful or painless swelling over the bones that will subsequently be lysed. All osteolyses are dynamic processes that ultimately result in replacement of bone and cartilage by fibrous tissue. Carpotarsal osteolysis is heralded by swelling and pain over the wrists and ankles at age three to four years. Phalangeal osteolysis, the most benign of the hereditary osteolyses, is a progressive process that involves only the distal phalanges. Multicentric osteolysis commonly affects the cranium, phalanges, carpals, and tarsals, although it may affect any bone. The cause of cessation of the lytic process is no less mysterious than the cause of its onset. Prognosis: Many patients are left with deformations at the joints adjacent to affected areas that may limit mobility and dexterity. By virtue of its location, it provides a measure of protection for the anterior aspect of the knee joint but becomes important to the function of the knee only if it is dislocated. Radiographs show no patella ossification and a flattening of soft tissues over the anterior aspect of the knee. Since patella diameter is a feature of continuous variation, the majority of small patellas represent simply the lower extreme of normal anatomical variation. In a minority of cases, underdevelopment is a feature of a multiple anomaly syndrome or skeletal dysplasia. The cartilaginous template of the patella, however, is present at birth and can be palpated in the distal aspect of the quadriceps tendon. Ossification generally proceeds from several foci, and the margins may be quite irregular. Abnormalities of ossification of the patella are seen in a number of circumstances. Irregular ossification or stippling of the patella also occurs in hypothyroidism and in other disorders that include stippled epiphyses. Goeminne L, Dujardin L: Congenital coxa vara, patella aplasia and tarsal synostosis: a new inherited syndrome. Carter C, Sweetnam R: Familial joint laxity and recurrent dislocation of the patella. Hall Multiple congenital contractures have been recognized for hundreds of years; however, the term arthrogryposis multiplex congenita was coined early in the 20th century to describe infants with multiple congenital contractures in various body areas. Shortened to arthrogryposis, the term now is used as a sign rather than as a specific diagnosis. Arthrogryposis is found in a very heterogeneous group of conditions including well-known syndromes and nonspecific associations. Thus, bilateral clubfeet would not be arthrogryposis, whereas a clubfoot and a dislocated hip would be considered to be within the preview of arthrogryposis. The medical literature on congenital contractures is rather confusing, because many authors have tended to lump together all the patients with congenital contractures and draw conclusions that may apply to only one subgroup of patients. The presence of multiple congenital contractures is very obvious at birth, and the diagnosis is now often made prenatally by ultrasound studies. It may be necessary to observe a fetus for up to 45 minutes in utero with real-time ultrasound to determine whether there is normal movement of various Normally the patella rests in the diamond formed by the femorotibial junction and the concavities of the femoral and tibial epiphyses. In the series of Bowker and Thompson, 75 percent of cases occurring after age three years were not familial. However, it is clear that prenatal diagnosis of conditions with multiple congenital contractures is usually missed because of failure to look for movement prenatally. The particular pattern of contractures, the specific body areas involved, the presence of flexion versus extension contractures, and involvement of the jaw and/or trunk may be very helpful in arriving at a specific diagnosis. There are over 400 specific conditions in which congenital contractures are regularly seen; thus a practical approach to diagnosis is needed. Recently, over 150 genes have been identified to have mutations associated with arthrogryposis and almost any chromosomal deletion or duplication may have congenital contractures (often related to in utero hypotonia). However, in at least 30 percent of individuals with multiple congenital contractures, no specific diagnosis can be established in the newborn period. It is particularly important in such cases to take photographs to document the position of contractures in the newborn period, since they may well change with therapy. The positioning in the newborn period is important in the differential diagnosis process as well. The specific diagnosis and prognosis may only emerge over time with repeated evaluation.

In addition anxiety attacks symptoms treatment trusted 75 mg imipramine, the patient may have a drug interaction that affects a bodily system not usually monitored by the specialist anxiety symptoms chills order generic imipramine. Finally anxiety symptoms gad imipramine 25 mg order without a prescription, the patient might not associate a symptom with a particular drug that has been used anxiety medication list buy imipramine discount, if that symptom is not related to the system for which the drug was given anxiety natural supplements imipramine 25 mg low cost. The advent of electronic medical records has helped physicians deal with the multiple drug regimens but has not eliminated the problem. For example, the commonly prescribed erectile dysfunction agent sildenafil has been noted to block photoreceptor signals, causing electroretinographic changes, visual disturbances (including changes in color perception), and increased light sensitivity. The incidences of major defects appear highest among spontaneous abortions, intermediate in stillborn infants, and lowest among liveborn infants. As noted above, the incidence of major anomalies recognized at birth among liveborn infants is 2 to 3 percent (Table I. An equal number of additional major anomalies will be recognized by age five years. In many ways, when one appreciates the complexity of the developmental processes involved, it is surprising that the frequency of congenital anomalies in humans is not higher. Minor anomalies are relatively frequent structural alterations that usually pose no significant health or social burdens (Tables I. The presence of two or more minor anomalies is an indication that a major defect and/or syndrome may be present as well (Table I. They can also provide a clue to the timing of an insult during prenatal development (as in the cases of flexion creases in the hands). At least 15 percent of newborn infants have one or more minor structural anomalies (Table I. A higher incidence may be found among premature infants and infants with intrauterine growth restriction have an even higher rate. The risk of having a major structural abnormality increases with the number of minor anomalies present. Infants free of minor anomalies have a low incidence (approximately 1 percent) of major malformations. Those infants with two minor anomalies have a 10 percent risk of a major malformation, and those with three or more minor anomalies have a 20 percent risk of a major structural abnormality. No clear distinction exists between normal variation and minor anomalies or between minor anomalies and major anomalies. Holmes separates minor anomalies from normal variants by considering as normal those features that occur in 4 percent or more of the population. The level of sensitivity to minor anomalies is set differently by different observers. Downslanting palpebrae, horizontal palmar creases, asymmetric ears, preauricular skin tags, and clinodactyly are among those features with similar incidences at birth and at one year. A 50 percent or greater reduction in the prevalences of high-arched palate, low-set ears, and upslanting palpebral fissures occurs by one year. This contrasts with the increased detection of major defects during the first year of life. Prenatal alcohol syndrome and prenatal hydantoin syndrome, for example, are more commonly diagnosed by a pattern of minor morphologic features than on the basis of major malformations. Syndrome, association, complex, spectrum, sequence, field defect, and phenotype have all been used to describe some composite of anatomic features. Johannsen originally coined the term phenotype to encompass the outward manifestations produced by an individual gene. Genotype and phenotype can refer to a single gene and its manifestations (anatomic, biochemical, physiologic), to a related group of genes and their manifestations, or to the entire genetic constitution and all resulting hereditary features. In current usage, phenotype has become a general term for describing a composite of features without regard to the underlying cause. This more general use of phenotype in many cases suggests that the cause of the features is uncertain or that multiple causes might produce this composite of manifestations. In some cases a modifier is added to indicate pathogenesis, for example, akinesia phenotype to indicate those features that are produced by absence of prenatal movement from any cause. Complex has been a general term that is also used to indicate a composite of manifestations. Spectrum is sometimes used to describe entities with multiple features, particularly those in which prominent features can be expressed with considerable variation and range of severity. Greater specificity is suggested by the term syndrome, which means a group of features seen together in multiple individuals and also implies that the composite of features has a common, specific etiology (although, of course, this can also include a pathway along which there can be many different perturbations all leading to similar end results). Use of the term syndrome indicates that a specific diagnosis has been made and that the natural history and recurrence risk are known. The reader will recognize that syndrome is also used widely in medicine without the specificity suggested above when used to describe structural anomalies. Use of association does not imply a specific diagnosis or evidence of a common cause. Recognition of such statistically related anomalies prompts the search for other defects when one component of an association is noted. Sequence has been used by some to indicate a pattern of anomalies that results from a single primary anomaly or single mechanical factor. The anomaly or mechanical factor that initiates the sequence may produce multiple secondary anomalies or may produce a secondary anomaly that leads to a tertiary anomaly, and so forth in cascade fashion. For example, in Pierre Robin sequence, severe micrognathia is the primary anomaly, which causes secondary glossoptosis, which obstructs palatal shelf closure, ultimately resulting in a cleft palate. Confusion can arise because of the longstanding use of sequence for the arrangement of nucleotides and codons in the genome. Multiple anomalies can also be related through the time period during which they develop. A single insult during embryogenesis may affect multiple unrelated structures that are being formed at the time. In the absence of evidence that links the pathogenesis of widely diverse and seemingly unrelated components of conditions with multiple features, these components have been considered "pleiotropic effects" of the underlying cause. The naming of composite entities (syndromes, associations, phenotypes) follows no fixed rules nor does it have any committee-assumed authority for naming. Authors and editors often designate a name in the initial description of an entity, or one arises in a subsequent review. For conditions of known etiology, names that acknowledge the cause would seem to be most appropriate (trisomy 13 syndrome, prenatal alcohol syndrome). This is not possible for many syndromes caused by single genes, several genes, or for conditions of unknown etiology. If the major components are few, their enumeration in the name is possible (hypertelorism-hypospadias syndrome). These approaches offer the user some mnemonic assistance in recalling the primary features of the entities. Perhaps the most widely used practice in naming composite entities has been to use eponyms. Eponymic designation attempts to credit the individual(s) who first described IntroductIon 7 an entity or who first recognized it to be a specific entity. Not uncommonly, earlier reports of an entity are overlooked or not recognized to be that entity, leading to competing names or to compound eponyms (de Lange syndrome versus Brachmann-de Lange syndrome). Problems are also encountered when a prolific investigator describes more than one entity (Fanconi anemia syndrome and Fanconi renotubular syndrome). When heterogeneity is found to exist in an established name, renaming becomes necessary (Lawrence-Moon-Bardet-Biedl syndrome now divided into Lawrence-Moon syndrome and Bardet-Biedl syndrome, with several subtypes of Bardet-Biedl). These difficulties aside, the use of eponyms appears well established and will likely be replaced only by naming according to etiology (based on the gene or the environmental insult responsible). Postnatal alteration of an anatomic part should be distinguished from prenatal alteration, and prenatal alteration during organogenesis should be distinguished from alteration after organogenesis. It gives no sense of pathogenesis and causation, nor does it imply initiation or occurrence at any particular time during prenatal (or immediate neonatal, in the case of birth-related events) life. Hence the use of congenital with malformation, disruption, or deformation in the sense described here would be redundant. Congenital anomaly, congenital defect, or congenital abnormality would be more appropriate term combinations, since their use would restrict the general terms anomaly, defect, and abnormality to those present at birth. These terms imply a structural problem without specifying the etiology, which can be useful at times. It should be noted that families often consider the term defect pejorative; thus, the term anomaly is usually preferable. They imply nothing about the gene expression and flow of biochemical changes underlying the morphologic events. The age of an embryo is given in days following ovulation (developmental or embryonic age). Embryonic (postovulation) age is thus two weeks less than menstrual age (gestational age), which are the days or weeks following onset of last menstrual period; the latter age has been commonly used to date pregnancies in obstetrics and neonatology. Fertilization is thought to generally occur within 24 hours after ovulation, usually in the outer reaches of the Fallopian tubes. The initial four stages of human development take place during the preimplantation period over the first five or six days and span the early series of divisions of the free-floating conceptus up to and including the early implantation process. In the latter half of the preimplantation period, the conceptus is called a blastocyst, which is a mass of cells with an internal fluid-filled cavity. Implantation occurs during stages four and five, which span the embryonic/developmental period of 5. The embryonic disc becomes bilaminar (ectoderm and endoderm), and the amniotic cavity develops on the epidermal surface and the yolk sac on the endodermal surface during these stages. The phenotypic description of the developing embryo often ignores the placenta and membranes, which simultaneously undergo significant morphologic and metabolic changes. Placental size and shape are gaining increasing recognition as important in predicting adult chronic diseases. The beginning of marrow formation in the humerus is a developmental landmark used to assist in identifying this stage. The first eight weeks after fertilization are generally considered the period of embryogenesis. The embryo has taken human form, and most organs are formed and located in their final position by the end of this period. Exceptions exist, however, and include external genitalia, abdominal wall, heart, and dental structures and, of course, the brain, which continues its development (partly in response to utilization of neuronal pathways) into childhood. The fetal period begins with week nine (week 11 of gestation) and extends until delivery, usually 40 weeks from the last menstrual period and 38 weeks from fertilization. Growth and maturation of function are the major processes that occur during this fetal period. However, as noted above, formation of some structures continues into the fetal period and may be influenced by mechanical and vascular flow considerations as well as gene expression. External genitalia do not complete differentiation until embryonic week 12, hair follicles do not form until week 12, the midgut does not return to the abdominal cavity from the body stalk until embryonic week 10, and teeth do not gain their definitive morphology until much later in fetal life. An interesting new field related to fetal determinants of adult health suggests that events during fetal life can have long-lasting effects on metabolism, psychological development, and immunologic response later in life. For instance, intrauterine growth restriction is associated with an increased risk for the development of diabetes, coronary artery disease, and hypertension in adulthood. The mechanisms by which these influences occur are not yet clear but include epigenetic changes and may be transgenerational. In the strict sense, malformations (as previously defined) occur during the period of organ formation. Most will occur during the first eight weeks, but exceptions to this are not uncommon in structures that are still forming after eight weeks. In general, disruptions and deformations occur following morphologic formation and hence for the most part occur after eight weeks postovulation. Some terms are particularly useful in defining environmental influences that act during gestation and that alter morphology, function, or growth. First, as its derivation (teratos = monster, gen = produce) suggests, the end result of a teratogenic influence will be a morphologic abnormality rather than just a functional one (however, of course, both morphologic and functional changes can be expected). Third, teratogens exert their influence following fertilization and before delivery. Teratogens have an effect primarily during the first eight weeks of embryogenesis, causing malformations, but may act at a later point in pregnancy causing disruptions or deformations as well, such as those seen with maternal warfarin use. These late effects of teratogens can also include malformation of structures that are still forming after the usual eight weeks of embryogenesis. When known, these processes can be used as descriptive modifiers or to imply pathogenesis, as in the chondroosseous dysplasias. For all human anomalies, the etiologic possibilities are limited to genetic (single gene, multiple genes, chromosomal) or to environmental (mechanical, infectious, chemical) causes or to some combination of the two. Little regard for etiology is given when naming individual structural anomalies; however, the etiology can be found in the names of many syndromes (trisomy 13 syndrome, fetal alcohol syndrome, X-linked hydrocephaly syndrome). Again, little indication of pathogenesis is incorporated into the names of individual structural anomalies, but considerable emphasis is given in the naming of entities with multiple features (early amnion rupture, oligohydramnios sequence). As more is learned about the role of gene expression Aplasia indicates absence of cellular proliferation, hence the absence of tissue mass and consequently of an organ or morphologic feature. Hypoplasia indicates insufficient cell proliferation, resulting in a deficiency of tissue mass and ultimately undergrowth of an organ or morphologic feature. Similarly, hyperplasia means excessive proliferation of cells, accumulation of excessive tissue mass due to the increased cell number, and overgrowth of an organ or morphologic feature. Dysplasia as used in clinical genetics implies disorganization of cell structure, disordered cell arrangement in tissues, and resulting abnormal tissue organization in an organ or morphologic feature. At the tertiary (organ) level, these terms are best used only when the underlying histology is known.

Initially the mandible is flattened across the lower region of the face anxiety symptoms in adults generic imipramine 50 mg without prescription, but during the next couple of weeks it grows forward extensively to create room in the oral cavity for formation of the tongue anxiety and high blood pressure generic imipramine 75 mg with visa. The posterior regions of the mandible also grow to form the rami anxiety 3 months postpartum buy on line imipramine, thereby causing the external ears anxiety symptoms urination order genuine imipramine online, which are closely associated with this portion of the mandible anxiety hierarchy 25 mg imipramine purchase with visa, to move superiorly and to rotate into their definitive position. The lip is a mosaic structure composed of the frontonasal (1), left maxillary (2), left mandibular (3), right mandibular (4), and right maxillary (5) processes. In: Understanding Craniofacial Anomalies: the Etiopathogenesis of Craniosynostoses and Facial Clefting. Poorly controlled maternal diabetes imparts a 200-fold increased risk for holoprosencephaly. It is more common in early human embryos than the prevalence numbers for stillborn and liveborn infants would suggest, reflecting early embryonic loss. In a retrospective review of pregnancy outcome linking prenatal and postnatal databases in a defined region England, 11 cases of midline cleft lip were identified prenatally (of 570 total). In addition to holoprosencephaly, median cleft lip may be one feature of several genetic conditions caused by mutations in genes that disrupt the function of cilia-components of almost all vertebrate cells that are involved in signal transduction. The second group of conditions presenting with median cleft lip are the frontonasal dysplasias, which are characterized by significant ocular hypertelorism and frequently normal cognitive function despite the facial malformation. The defect may range from a subtle notch in the middle of the lip to absence of the premaxilla with a flaplike nose. Since many median clefts of the lip are part of the holoprosencephaly spectrum, the diagnosis is increasingly made on prenatal imaging. Median cleft lip appears to be one of the intermediate phenotypes seen with holoprosencephaly. Treatment: the approach to treatment depends greatly on the underlying cause of the median cleft lip. Some of the disorders associated with median cleft lip have limited potential for survival, whereas others have normal survival and normal cognitive potential. Children with severe defects in brain development typically need gastrostomy tubes. The American Cleft Palate-Craniofacial Association has published parameters of care for children with cleft lip and palate. For median clefts associated with the more severe forms of holoprosencephaly, a reduced lifespan is anticipated. Survivors have varying degrees of intellectual disability, seizures, diabetes insipidus, and other pituitary deficiencies. American Cleft Palate-Craniofacial Association: Parameters for Evaluation and Treatment of Patients with Cleft Lip/Palate or Other Craniofacial Anomalies. With the exception of occult defects in the lip, most clefts of the lip and palate are readily apparent on physical examination at birth. The most subtle manifestation of cleft lip may be a fibrous band of scar-like tissue along the philtral ridge. More typically, there is an obvious gap between the premaxillary and lateral aspects of the upper lip that continues through the alveolar ridge and the secondary palate when the cleft is complete. In a unilateral cleft there is flattening of the alar rim on the affected side and deviation of the nasal septum toward the non-cleft side. The concordance rate among monozygotic twins is 6­19 times the rate in dizygotic twins, whose likelihood of being affected is the same as that of a full sibling. The empiric recurrence risk for first-degree relatives is from 3 percent to 5 percent. A Increasingly, clefts of the lip with or without cleft palate are recognized prenatally at the second-trimester anatomy scan. Newer estimates suggest that susceptibility may be conferred by two to eight genes acting in a multiplicative fashion in conjunction with specific environmental risk factors. Recent systematic review of the literature has documented that the prevalence of associated anomalies with prenatally diagnosed cleft lip alone ranges from zero to 20 percent and for cleft lip plus palate ranges from 39. For clefts ascertained postnatally, the prevalence of associated abnormalities in cleft lip alone varied from 7. D: Incomplete bilateral cleft lip with overt cleft below the right nostril and occult cleft below the left nostril. Reconstruction is accomplished in a staged fashion as an individual grows and develops, mandating longitudinal follow-up through completion of growth. Treatment decisions necessarily weigh aesthetic and speech concerns against issues of facial growth. The former dictates early repair because of evidence that speech results are better if a reconstruction is performed prior to the development of expressive language. Data from an international collaborative project have suggested that better outcomes are achieved in multidisciplinary centers using a few experienced operators and relatively simple protocols as opposed to centers with multiple operators and no consistent protocol. In addition, up to 25 percent will need management of velopharyngeal insufficiency. Middle ear disease is frequent, and ventilation tubes are commonly placed with a soft tissue surgery. Many children with involvement of the secondary palate will require speech therapy to address issues of language, compensatory, and other articulation. Between 7 percent and 48 percent of cases may require midface advancement to address skeletal malocclusion. Although the worldwide birth prevalence is 5:10,000, much higher rates have been recorded in Finland, Scotland and Canada, with low rates in Africa. Abnormalities in closure are posterior to the incisive foramen and may involve hard and soft palate, soft palate only, or be submucous in nature such that there is only muscle discontinuity below an intact mucosa. Overt clefts of the palate are readily identified on physical examination provided the oral cavity is adequately examined. The V-shaped cleft is more common and typically not associated with airway issues if isolated. The U-shaped cleft palate is seen in infants with significant micrognathia associated with posterior displacement of the tongue in the oral cavity and glossoptosis, the Robin sequence. It is postulated that early-onset micrognathia in these cases prevented descent of the tongue in the oral cavity such that palatal closure was blocked. Infants with Robin sequence typically have unstable airways and failure to thrive for the first months of life if the airway concerns are not addressed. The diagnosis of submucous cleft palate rests on the triad of (1) notching of the posterior border of. Moreover, the diagnosis may not be apparent in infancy, as 18 percent of presumed "isolated" Robin sequence will have a change in diagnosis if followed over time. The American Cleft Palate-Craniofacial Association has published parameters of care for affected children. A typical infant should undergo primary palate repair prior to a year of age, as speech outcomes seem to be better if the palate is repaired before expressive language develops. Up to 25 percent will develop velopharyngeal insufficiency, often requiring secondary palatal surgery. Middle ear disease is frequent, and ventilation tubes are commonly placed at the time of palate surgery. Many children with cleft palate will require speech therapy to address delayed language, compensatory, and other articulation errors. Perhaps we are making inroads for change through efforts to reduce dental healthcare disparities among children, the elderly, and those with chronic disease, efforts that one day may allow the mouth to once again be considered part of the body. Abnormal embryonic development of the tongue may produce alterations in the formation of the thyroid gland, with resultant ectopia (lingual thyroid). Midline clefting of the mandible may be associated with absent, cleft, or adherent tongue, while macroglossia, as in Beckwith-Wiedemann syndrome, can influence tooth position and alignment. In addition, microstomia will be present if the tongue is nearly absent, as in hypoglossia-hypodactyly syndromes or in otocephaly. Speech alterations may be present in cases of ankyloglossia, and diastema of mandibular incisors can occur in cases of thick lingual frenulum with insertion into the anterior labial mucosa. As will become clear, developmental abnormalities of the tongue are highly diverse and can carry significant morbidity and, on occasion, life-threatening airway compromise. The posterior one-third of the tongue (the root) is derived primarily from the third arch that overgrows tissue from the second and fourth arches. The epiglottis and the extreme posterior of the tongue are derived from fourth arch tissue. The line of fusion between the body and root of the tongue is represented by the terminal sulcus. Muscles for the tongue are derived from myotomes originating from occipital somites. The tongue is composed of four extrinsic muscles (genioglossus, hyoglossus, styloglossus, palatoglossus) and four intrinsic muscles (superior and inferior longitudinal, verticalis, transversus). This complex muscle group gives the tongue remarkable versatility of movement, allowing for its role in speech, chewing, swallowing, and even gesturing due to its unique ability to be protruded into space. Beyond these functions, the tongue is also a sensory organ capable of sensing the basic tastes of sweet, salt, bitter, and sour, and, because of the presence of the lingual tonsil, serving as an organ of the immune system. The tongue is usually considered to have two parts: the anterior two-thirds of the tongue (the oral portion), which is separated from the posterior third (the pharyngeal portion) by the sulcus terminalis. The vallate and foliate papillae appear earliest and have a relationship to the terminal branches of the glossopharyngeal nerve. The fungiform papillae, also scattered over the same area but fewer in number, arise somewhat later embryologically, having a relationship to the termination of the chorda tympani branch of the facial nerve. The filiform papillae covering the dorsum of the anterior two-thirds of the tongue appear after week 12, and the vallate papillae appear along the sulcus terminalis and the foliate papillae on the posterolateral surface of the tongue. A second medial swelling, called the copula or hypobranchial eminence, forms from mesoderm of the second, third, and fourth arches, while a third midline swelling, signaling development of the epiglottis, forms from the posterior region of the fourth arch. The mesenchymal component of the tongue is derived from cranial neural crest cells of the component pharyngeal arches. The myogenic regulatory factors play roles in the determination and terminal differentiation of tongue myoblasts. Morphogenesis of the tongue is guided by tissue­tissue interactions between cranial neural crest and invading myoblasts. Gorlin, who authored the chapter in Edition 2 of Human Malformations and Related Anomalies on which this revision is based. The taste buds of the anterior two-thirds of the tongue are innervated by the chorda tympani branch of the seventh nerve. The foliate papillae and the posterior one-third of the tongue are innervated by the glossopharyngeal nerve. The superior laryngeal branch of the vagus nerve supplies a small area of the tongue just anterior to the epiglottis, and, as indicated earlier, the muscles of the tongue are supplied by the hypoglossal nerve except for the palatoglossus, which is supplied by the vagus. Parada C, Han D, Chai Y: Molecular and cellular regulatory mechanisms of tongue myogenesis. All examples of hypoglossia-hypodactylia, Moebius syndrome, and the oromandibular-limb hypogenesis syndromes have been sporadic. There is evidence to suggest that prenatal exposure to misoprostol is associated with an increased risk of Moebius syndrome. Surgical resection of mandibulo-palatine or other intraoral synechiae, if present, can improve mandibular excursion. Prognosis: Although most patients have intelligible speech, hypoglossia can have a significant negative effect on articulation. Due to its association with a wide variety of conditions, anomalies of virtually all organ systems have been noted. Laboratory studies: mutational testing in cases suspected to represent Beckwith-Wiedemann syndrome or other less common causes of macroglossia. Acquired macroglossia includes such categories as neoplasms (lymphoma, carcinoma), systemic disorders (amyloidoses), and local reactive change (angioneurotic edema) (Table 18. Relative macroglossia refers to a tongue that appears large despite its normal size. This is usually due to neurologic (lingual dystonia) or developmental (maxillary/mandibular hypoplasia) causes. Again, relative macroglossia has been divided into congenital (trisomy 21) and acquired (edentulousness, myxedema) causes (Table 18. If the tongue enlargement is massive, the dorsal surface may be dried, cracked, ulcerated, infected, or hemorrhagic. The two lateral lingual swellings and a median swelling (tuberculum impar), which form the anterior two-thirds of the tongue, are derived from the first arch. During early stages of development, the tongue is fused to the floor of the mouth. Separation is achieved by cell death, the lingual frenulum being the only remaining tissue in this area. Absence of the frenulum occurs when the normal cell death extends beyond the normal limits. If associated with a syndrome, the prognosis is related to the underlying condition. Complete ankyloglossia occurs when the tongue is incompletely separated from the floor of the mouth. Two lateral lingual swellings and a medial swelling (tuberculum impar) form the anterior two-thirds of the tongue. During early stages of development, the tongue is attached to the floor of the mouth. The frenulum is normally the only remaining tissue in the ventral midline of the tongue attached to the floor of the mouth. Ankyloglossia can be divided into three types: (1) isolated partial ankyloglossia in which the frenulum of the tongue is anteriorly displaced and restricts protrusion of the tongue tip, (2) complete ankyloglossia in which the tongue is incompletely separated from the floor of the mouth, and (3) lateral ankyloglossia in which the lateral aspect of the tongue is fused with the alveolar gingiva or the medial edge of the palate in a child with a cleft palate.

25 mg imipramine buy. No Surgery - No Drugs: Performance Anxiety and Blushing Resolved.

References